vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and AMDOCS LTD (DOX). Click either name above to swap in a different company.

AMDOCS LTD is the larger business by last-quarter revenue ($1.3B vs $749.2M, roughly 1.7× CLOVER HEALTH INVESTMENTS, CORP.). AMDOCS LTD runs the higher net margin — 11.2% vs 3.6%, a 7.6% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 1.1%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 4.5%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Amdocs Limited is a multinational telecommunications technology company headquartered in Chesterfield, Missouri. The company specializes in software and services for communications, media and financial services providers and digital enterprises. Amdocs was founded in 1982 and is publicly traded on the Nasdaq stock exchange.

CLOV vs DOX — Head-to-Head

Bigger by revenue
DOX
DOX
1.7× larger
DOX
$1.3B
$749.2M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+60.9% gap
CLOV
62.0%
1.1%
DOX
Higher net margin
DOX
DOX
7.6% more per $
DOX
11.2%
3.6%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
4.5%
DOX

Income Statement — Q1 FY2026 vs Q3 FY2024

Metric
CLOV
CLOV
DOX
DOX
Revenue
$749.2M
$1.3B
Net Profit
$27.3M
$140.3M
Gross Margin
Operating Margin
3.6%
14.1%
Net Margin
3.6%
11.2%
Revenue YoY
62.0%
1.1%
Net Profit YoY
-12.0%
EPS (diluted)
$0.05
$1.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
DOX
DOX
Q1 26
$749.2M
Q4 25
$487.7M
Q3 25
$496.6M
Q2 25
$477.6M
Q1 25
$462.3M
Q4 24
$337.0M
Q3 24
$331.0M
Q2 24
$356.3M
$1.3B
Net Profit
CLOV
CLOV
DOX
DOX
Q1 26
$27.3M
Q4 25
$-49.3M
Q3 25
$-24.4M
Q2 25
$-10.6M
Q1 25
$-1.3M
Q4 24
$-22.1M
Q3 24
$-9.2M
Q2 24
$7.4M
$140.3M
Gross Margin
CLOV
CLOV
DOX
DOX
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Operating Margin
CLOV
CLOV
DOX
DOX
Q1 26
3.6%
Q4 25
-10.1%
Q3 25
-4.9%
Q2 25
-2.2%
Q1 25
-0.3%
Q4 24
-6.4%
Q3 24
-2.7%
Q2 24
2.0%
14.1%
Net Margin
CLOV
CLOV
DOX
DOX
Q1 26
3.6%
Q4 25
-10.1%
Q3 25
-4.9%
Q2 25
-2.2%
Q1 25
-0.3%
Q4 24
-6.6%
Q3 24
-2.8%
Q2 24
2.1%
11.2%
EPS (diluted)
CLOV
CLOV
DOX
DOX
Q1 26
$0.05
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$1.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
DOX
DOX
Cash + ST InvestmentsLiquidity on hand
$177.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$339.4M
Total Assets
$697.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
DOX
DOX
Q1 26
$177.6M
Q4 25
$78.3M
Q3 25
Q2 25
Q1 25
Q4 24
$194.5M
Q3 24
$288.0M
Q2 24
$254.8M
Stockholders' Equity
CLOV
CLOV
DOX
DOX
Q1 26
$339.4M
Q4 25
$308.7M
Q3 25
$340.9M
Q2 25
$344.2M
Q1 25
$336.1M
Q4 24
$341.1M
Q3 24
$342.2M
Q2 24
$324.9M
Total Assets
CLOV
CLOV
DOX
DOX
Q1 26
$697.7M
Q4 25
$541.0M
Q3 25
$559.7M
Q2 25
$575.0M
Q1 25
$583.7M
Q4 24
$580.7M
Q3 24
$653.0M
Q2 24
$674.2M

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons